<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01287455</url>
  </required_header>
  <id_info>
    <org_study_id>483 CTIL</org_study_id>
    <secondary_id>Vitamin D</secondary_id>
    <nct_id>NCT01287455</nct_id>
  </id_info>
  <brief_title>The Effect of Vitamin D Replacement on Airway Reactivity, Allergy and Inflammatory Mediators in Exhaled Breath Condensate in Vitamin D Deficient Asthmatic Children</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <brief_summary>
    <textblock>
      Research Title: The effect of vitamin D replacement on airway reactivity, allergy and
      inflammatory mediators in exhaled breath condensate in vitamin D deficient asthmatic
      children.

      Introduction: Vitamin D seems to play a role in allergic and asthmatic reactions as an
      immunomodulator. Asthma disease involves inflammatory process in the lower respiratory tract
      and airway hyperreactivity.

      Aim: To assess the effect of Vitamin D replacement on airway reactivity, and allergy and
      inflammatory mediators in exhaled breath condensate in vitamin D deficient asthmatic
      children.

      Design: Double blind placebo control prospective study comparing the effect of Vitamin D
      replacement and placebo on airway reactivity, allergy and inflammatory mediators in exhaled
      breath condensate in asthmatic pediatric population with vitamin D deficiency.

      Participant selection: The study group will consist of pediatric patients (age 6-18 years)
      followed and treated at the Pediatric Pulmonary Unit at the investigators hospital.

      Patients with mild-moderate asthma with low or insufficient vitamin D levels that are
      currently not receiving anti-inflammatory treatment will be recruited.

      Sample size: 60 participants in the two groups (30 receiving Vitamin D and 30 receiving
      placebo).

      Intervention: Vitamin D (14000 units) or placebo will be provided in a similar appearance
      preparation once weekly for 6 weeks between visit two and three.

      Three visits will be conducted. Each subject will undergo evaluation including a respiratory
      questionnaire (visit 1), methacholine challenge test with determination of PC20 (visit 1 or 2
      and visit 3), exhaled nitric oxide (eNO) (visit 2, 3), and exhaled breath condensate (EBC)
      (visit 2,3). Venous blood will be analyzed for complete blood count + eosinophils (visit 1,
      3), IGE levels (visit 1, 3), and Vitamin D levels (visit 1, 3). Prick skin test for inhaled
      allergens will be performed (visit 2, 3).

      Primary end point: Airway reactivity as assessed by methacholine challenge test.

      Secondary outcome parameters: All other parameters are the secondary end points.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Metacholine Challenge Test</measure>
    <time_frame>study visit 1,3 (6wks- 3 months)</time_frame>
    <description>As assessed by methacholine challenge test with determination of PC20.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>IGE</measure>
    <time_frame>study visit 1,3 (6wks- 3 months)</time_frame>
    <description>in peripheral Blood count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CBC</measure>
    <time_frame>study visit 1,3 (6wks- 3 months)</time_frame>
    <description>in peripheral Blood count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fractional Exhaled NO</measure>
    <time_frame>visit study 2,3 (6wks)</time_frame>
    <description>determination of exhaled NO in Exhaled breath</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>skin tests for inhaled allergens</measure>
    <time_frame>visit study 2,3 (6wks)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exhaled breath condensate</measure>
    <time_frame>visit study 2,3 (6wks)</time_frame>
    <description>R-tubes test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">83</enrollment>
  <condition>Asthma</condition>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>vitamin D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>vitamin D deficient asthmatic patients receiving vitamin D supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>vitamin D deficient asthmatic patients receiving placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D3 as &quot;BABY D3&quot;</intervention_name>
    <description>drops, 70 drops (= 14000 units), once weekly for 6 weeks</description>
    <arm_group_label>vitamin D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>drops, 70 placebo drops, once weekly for 6 weeks</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  6-18 years

          -  Mild-moderate asthma

          -  No anti inflammatory treatment over the past 2 weeks

        Exclusion Criteria:

          -  Any Chronic Lung Disease

          -  Febrile Illness in last 2 weeks

          -  FEV1 &lt; 65% in study day

          -  Bronchodilators over the past 24 hours prior to each study

          -  Participation in any other clinical studies over the past 4 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lea Bentur, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>RAMBAM Health Care Campus</name>
      <address>
        <city>Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2011</study_first_submitted>
  <study_first_submitted_qc>January 31, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2011</study_first_posted>
  <last_update_submitted>June 12, 2013</last_update_submitted>
  <last_update_submitted_qc>June 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Vitamin D</keyword>
  <keyword>airway reactivity</keyword>
  <keyword>metacholine challenge test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

